Inventor · disambiguated record
Karen Lingnau
Also filed as: LINGNAU KAREN
12 granted patents·14 pending applications·130 citations·filing 2001–2022
90Inventor score
Files withINTERCELL AG11BUSCHLE MICHAEL4HOOKIPA BIOTECH GMBH3VALNEVA AUSTRIA GMBH3CISTEM BIOTECHNOLOGIES GMBH1
Top patents by PatentIndex Score
26 records- 0192US7148191B2Antigenic compositionINTERCELL AG·Filed 2001·Granted Dec 12, 2006·58 cites·22 claims
- 0287US8765148B21C31 nanoparticlesWIZEL BENJAMIN·Filed 2011·Granted Jul 1, 2014·26 cites·10 claims
- 0386US8784837B2Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid moleculeBUSCHLE MICHAEL·Filed 2010·Granted Jul 22, 2014·7 cites·18 claims
- 0485US10111945B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2014·Granted Oct 30, 2018·13 cites·29 claims
- 0582US7704514B2VaccinesINTERCELL AG·Filed 2004·Granted Apr 27, 2010·14 cites·9 claims
- 0682US7244438B2Uses for polycationic compoundsINTERCELL AG·Filed 2002·Granted Jul 17, 2007·11 cites·4 claims
- 0778US11554169B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2018·Granted Jan 17, 2023·1 cites·55 claims
- 0872US2023181725A1Cmv vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0965US9492537B2Methods and compositions involving immunostimulatory oligodeoxynucleotidesVALNEVA AUSTRIA GMBH·Filed 2014·Granted Nov 15, 2016·0 cites·4 claims
- 1065US2008025996A1Methods and Compositions Comprising Polycationic CompoundsLINGNAU KAREN·Filed 2007·Application pending·0 cites
- 1163US8945591B2Methods and compositions involving immunostimulatory oligodeoxynucleotidesINTERCELL AG·Filed 2013·Granted Feb 3, 2015·0 cites·14 claims
- 1263US2007218073A1Antigenic compositionINTERCELL AG·Filed 2006·Application pending·0 cites
- 1362US2011236414A1Bacterial Polysaccharide-Polypeptide Conjugate CompositionsINTERCELL AG·Filed 2009·Application pending·0 cites
- 1457US2009155294A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1556US2009130135A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1655US2015010595A1Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid moleculeVALNEVA AUSTRIA GMBH·Filed 2014·Application pending·0 cites
- 1753US2007041998A1Use of alum and a th1 immune response inducing adjuvant for enhancing immune responsesINTERCELL AG·Filed 2004·Application pending·0 cites
- 1853US2007031446A1Hcv vaccinesINTERCELL AG·Filed 2004·Application pending·0 cites
- 1951US9248180B2IC31 nanoparticlesVALNEVA AUSTRIA GMBH·Filed 2014·Granted Feb 2, 2016·0 cites·17 claims
- 2051US8568742B2Methods and compositions involving immunostimulatory oligodeoxynucleotidesSCHMIDT WALTER·Filed 2001·Granted Oct 29, 2013·0 cites·13 claims
- 2145US2011300170A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2011·Application pending·0 cites
- 2243US2009186047A1HCV VaccinationsINTERCELL AG·Filed 2006·Application pending·0 cites
- 2342US7858588B2Immunostimulatory oligodeoxynucleic moleculesINTERCELL AG·Filed 2002·Granted Dec 28, 2010·0 cites·26 claims
- 2441US2002197269A1Pharmaceutical composition for immunomodulation and preparation of vaccinesCISTEM BIOTECHNOLOGIES GMBH·Filed 2002·Application pending·0 cites
- 2539US2004081655A1Methods and compositions comprising polycationic compoundsFiled 2002·Application pending·0 cites
- 2638US2005250716A1Immunostimulatory oligodeoxynucleotidesINTERCELL AG·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →